SFRS9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.708600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.928600E-01
Normal-vs-Stage2
9.203400E-01
Normal-vs-Stage3
4.205400E-01
Normal-vs-Stage4
4.202600E-01
Stage1-vs-Stage2
6.408800E-01
Stage1-vs-Stage3
2.977200E-01
Stage1-vs-Stage4
3.404200E-01
Stage2-vs-Stage3
3.051000E-01
Stage2-vs-Stage4
5.265000E-01
Stage3-vs-Stage4
7.844200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.732800E-01
Normal-vs-AfricanAmerican
5.683600E-01
Normal-vs-Asian
5.032000E-01
Caucasian-vs-AfricanAmerican
5.131600E-01
Caucasian-vs-Asian
1.632830E-01
AfricanAmerican-vs-Asian
7.260800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.382400E-01
Normal-vs-Female
8.657400E-01
Male-vs-Female
3.470600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.168400E-01
Normal-vs-Age(41-60Yrs)
6.836800E-01
Normal-vs-Age(61-80Yrs)
7.665000E-01
Normal-vs-Age(81-100Yrs)
6.169200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.818000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.025000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.362200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.686390E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.057600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.665420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.575000E-01
Normal-vs-Daily Drinker
8.685600E-01
Normal-vs-Weekly Drinker
2.468000E-01
Normal-vs-Occasional Drinker
2.479200E-01
Normal-vs-Social Drinker
7.330200E-01
Non Drinker-vs-Daily Drinker
4.454200E-01
Non Drinker-vs-Weekly Drinker
5.185600E-01
Non Drinker-vs-Occasional Drinker
1.368330E-02
Non Drinker-vs-Social Drinker
8.699800E-01
Daily Drinker-vs-Weekly Drinker
1.789050E-01
Daily Drinker-vs-Occasional Drinker
5.182200E-02
Daily Drinker-vs-Social Drinker
3.660400E-01
Weekly Drinker-vs-Occasional Drinker
7.160600E-03
Weekly Drinker-vs-Social Drinker
6.357600E-01
Occasional Drinker-vs-Social Drinker
1.315630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.728800E-01
Normal-vs-Grade 2
8.941800E-01
Normal-vs-Grade 3
8.263000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.214000E-01
Grade 1-vs-Grade 3
5.030400E-01
Grade 1-vs-Grade 4
8.728800E-01
Grade 2-vs-Grade 3
1.617410E-01
Grade 2-vs-Grade 4
8.941800E-01
Grade 3-vs-Grade 4
8.263000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.194800E-01
Normal-vs-NonDiabetic
9.990600E-01
Diabetic-vs-NonDiabetic
7.095400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.563600E-01
Normal-vs-NoPancreatitis
9.809000E-01
Pancreatitis-vs-NoPancreatitis
4.257600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.971200E-01
Normal-vs-N1
9.395200E-01
N0-vs-N1
7.780400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.767200E-01
Normal-vs-TP53-NonMutant
5.730200E-01
TP53-Mutant-vs-TP53-NonMutant
1.602370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
